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a b s t r a c t
Background: Atherosclerosis in Rheumatoid Arthritis (RA) patients may be aggravated by 
obesity.
Objective: To study the nutritional status of patients with RA.
Methods: Observational cross sectional study of 102 RA.  Patients were studied for clinical, 
demographic, serologic, activity and nutritional profile. In the latter we included: measure-
ment of body mass index (BMI), waist-hip ratio; bicipital skinfold (BSF) and their adequacy; 
triceps skinfold measure (TSF) and its adequacy and arm muscle circumference (AMC) and 
its adequacy.  Association studies of nominal data were done using Fisher and chi-square 
tests and the Mann Whitney and unpaired Student t tests for numerical data. For correla-
tion calculations the Spearman test was used. 
Results: In the sample there were 14/102 men, 88/102 women with mean age of 52.1 ± 11.5 
years and mean disease duration of 10.6 ± 7.47 years. The mean waist-hip ratio was 0.92 
± 0.07. According to BMI 30.3% had normal weight and 65.5% a total weight above normal. 
According to BSF, 74.5% were normal and 25.5% had depletion of muscular mass; accord-
ing to TSF, 83.3% were normal and 16.7% depleted. Association of nutritional variables with 
gender, rheumatoid factor, age, nodules, and disease activity showed no differences (p = 
NS) except for a lower waist/hip ratio in individuals with nodules (p = 0.02) and a modest 
correlation of TSF with disease duration (p = 0.02; R = 0.22; 95% CI = 0.01 to 0.40).
Conclusion: We found a high prevalence of overweight and obesity in patients with RA and 
a small frequency of muscle depletion. 
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r e s u m o
Objetivo: Estudar o perfil nutricional de pacientes com artrite reumatoide (AR).
Métodos: Estudo transversal observacional de 102 pacientes com AR. Os pacientes foram 
estudados para dados clínicos, demográficos, sorológicos, atividade de doença e perfil nu-
tricional. Neste último incluiu-se a medida do índice de massa corporal (IMC), relação qua-
dril/cintura, pregas cutâneas bicipitais (PCB) e sua adequação; prega cutânea tricipital (PCT) 
e sua adequação e circunferência muscular do braço (CMB) e sua adequação. Estudos de 
associação foram feitos usando os testes de Fisher e qui-quadrado para dados nominais 
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e teste t não pareado e Mann Whitney para dados numéricos. Para cálculo de correlação 
usou-se o teste de Spearman.
Resultado: Na amostra existiam 14/102 homens e 88/102 mulheres com idade média de 52,1 
± 11,5 anos e duração média de doença de 10,6 ± 7,4 anos. A relação cintura/quadril média 
era de 0,92 ± 0,07. De acordo com IMC, 30,3% tinham peso normal e 65,5% tinham peso 
acima do normal. De acordo com PCB, 74,5% eram normais e 25,5% tinham depleção; de 
acordo com a PCT, 83,3% eram normais e 16,7% tinham depleção. Associação de variáveis 
nutricionais com gênero, fator reumatoide, nódulos e atividade da doença não mostraram 
diferenças (p = NS) exceto, por uma relação cintura/quadril menor em indivíduos com nó-
dulos (p = 0,02) e uma correlação modesta da PCT com a duração de doença (p = 0,02; R = 
0,22; 95% IC = 0,01-0,40).
Conclusão: Existe uma alta prevalência de sobrepeso e obesidade em artrite reumatoide e 
uma pequena frequência de depleção muscular.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Rheumatoid arthritis (RA) is a chronic disease that affects 1% 
of Brazilian population1 and causes significant morbidity and 
mortality.1 Joint pain and fatigue associated with the inflam-
matory process, deformities that hinder the performance of 
daily activities result in work absenteeism, early retirement 
and economic losses.1,2,3 Among the causes of increased mor-
tality in these patients, accelerated atherosclerosis by the 
chronic inflammatory process with subsequent cardiovascu-
lar repercussions occupies a prominent role.2,3,4 It is estimat-
ed that a RA patient is 1.5 to 2 times more likely to develop 
myocardial infarction than the general population. This risk 
is comparable to that of a patient with diabetes mellitus type 
2 and can be increased by the traditional risk factors such as 
obesity.5
RA is an autoimmune disease with genetic and environ-
mental factors.2 The first explains the familial clustering of 
the disease and is responsible for the variability of the clinical 
and auto antibodies profiles.2 In the latter, smoking plays a 
major role.2 
In this context, one can conclude that nutritional factors 
should be studied and treated in RA, taking into account the 
genetic load and living habits of the population. In the pres-
ent work we studied the nutritional status of patients with RA 
in a population in Southern Brazil.
Methods
This is a cross-sectional study approved by the local Com-
mittee on Ethics in Research; all included participants signed 
consent.  The included subjects met at least four of the classi-
fication criteria for a diagnosis of RA of the American College 
of Rheumatology 19872 and were between 18 and 80 years. 
Pregnant patients and those with uncontrolled hypothyroid-
ism were excluded.
The anthropometric measurements were performed by a 
single dietitian prior to the consultation, who measured body 
weight, height, waist circumference, hip circumference, arm 
circumference, biceps and triceps skinfolds. The weight mea-
surement was performed by a digital balance Mars® and the 
height was measured using a stadiometer Cardiomed®. The 
body mass index (BMI) was calculated by dividing weight in 
kilograms by height in squared meters.6 The circumferences 
of the hip, arm and waist were made according to the tech-
nique described by Cuppari7 using an inelastic anthropomet-
ric tape. Measurements of skinfold thickness of biceps and 
triceps were made with the aid of a Cescorf® caliper accord-
ing to standardized technique described by Cuppari.7 Assess-
ment of skin folds adequacy was described by Frisancho8 and 
states that the patient is in severe malnutrition when the ad-
equacy of arm muscle circumference is less than 70%, with 
moderate malnutrition when it is between 70% and 80%, with 
mild malnutrition when between 80% to 90% and euthrophic 
when over 90%.
Medical records of patients were reviewed to obtain demo-
graphic and clinical data, duration of disease, autoantibody 
profile such as rheumatoid factor (RF), disease  activity (mea-
sured by DAS28 4v.).9,10
Data were collected on frequency and contingency tables. 
For association studies of nominal data we used the Fisher 
and chi-square tests, and for numerical data the Mann Whit-
ney and unpaired Student t tests. For correlation calculations 
we used the Spearman test. The calculations were made us-
ing the Graph Pad Prism Software®, version 5.0 (San Diego, 
California). The adopted significance was of 5%.
Results
Descriptive analysis of clinical and laboratory profile of the 
sample
Of the 102 patients, 14 (13.7%) were men and 88 (86.2%) were 
women, aged from 23 to 80 years (mean 52.1 ± 11.5 years), with 
age at diagnosis between 20 and 69 years (mean 41.9 ± 12.0 
years) and disease duration between 1 and 38 years (median 
9 years; IQI = 5-14,5). Of these, 9.8% had rheumatoid nodules. 
Rheumatoid factor was positive in 65.6%. The DAS28 ranged 
from 0.76 to 7.82 (mean 3.54 ± 1.53) and showed that 16.6% of 
patients had high activity, 33.3% had moderate activity, 21.4% 
had low activity and 28.6% were in remission of RA.
An analysis of treatments showed that 73.5% were on glu-
cocorticoid (dose from 2.5 mg to 60 mg/prednisone/day; me-
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Triceps Skinfold Adequacy: 
Euthrophic 52.9 
Light depletion 15.68 
Moderate depletion 4.9 








euthrophic light depleƟon moderate severe depleƟon
dian 10 mg), 66.6% used methotrexate, 44.1% antimalarial; 
29.4% leflunomide; 14.7% used biological therapy (14/102 anti 
TNF-α and 1/102 abatacept); 10.7% sulphasalazine and 2.9% 
azathioprine.
Descriptive analysis of nutritional assessment
The BMI of patients ranged between 16.0 and 45.5 kg/m2 
(mean of 27.9 ± 5.7 kg/m2). The BMI distribution in the sample 
can be appreciated in Fig. 1, which shows that most patients 
are above the accepted weight.
The study of the relation between waist and hip mea-
surements showed values  between 0.75 and 1.14 (mean 
0.92 ± 0.07). In 11/102 (10.7%), the waist hip ratio exceeded 1.0. 
Regarding arm circumference adequacy, we observed that it 
ranged from 68.6% to 136.2% (mean 99.9 ± 13.7%), and accord-
ing to this, 74.5% of the patients were eutrophic, 24.5% had 
mild depletion and 0.98% had severe muscle depletion.
Analysis of triceps skinfold adequacy showed values  be-
tween 24.4% and 336.4% (median 94.4%; IQI = 66.7-112.6). The 
distribution of findings regarding triceps skinfold adequacy 
can be seen in Fig. 2, that shows that almost half of patients 
have some degree of depletion. 
Analysis of arm muscle circumference adequacy showed 
values  between 76.7% and 142.4% (mean 103.3 ± 14.2%). Ac-
cording to this measure 83.3% of the population was eutro-
phic, 12.7% had mild depletion and 4% had moderate deple-
tion.
Studies of association and correlation between clinical 
variables and nutritional profile
No association/correlation was found between BMI, waist-hip 
ratio, brachial skinfold adequacy, triceps skinfold adequacy 
and adequacy of arm muscle circumference with patients 
gender, presence of rheumatoid factor, age, disease activity 
measured by DAS28 4v and use of glucocorticoid (p  =  NS). 
Patients without nodules have a higher value of waist-hip 
(p = 0.02) (Table 1). There was a modest correlation between 
triceps skinfold adequacy and disease duration (p  =  0.02; 
R = 0.22; 95% CI 0.01 to 0.40).
Discussion
The results of this study show that most patients with RA are 
above normal weight. This is an observation already made by 
other researchers: a multicenter study showed a prevalence 
of obesity in 18% of RA patients.11 Another study, made in Eng-
land, showed an even greater prevalence, of 31%.12 As in ours, 
in both studies more than 60% of patients had a higher than 
desired weight.
We also observed in the present analysis that, despite the 
increased BMI, most patients had normal or depleted triceps 
skinfold. As the latter assesses patient’s muscles, the current 
findings point to the fact that increased BMI occurs at the ex-
pense of adipose tissue rather than muscle gain.
There are several factors that contribute to an increased 
body fat and a decreased muscle mass in a patient with RA. 
One of these is, undoubtedly, the inactivity imposed by a pain-
ful and crippling joint disease.13 On one hand inactivity re-
duces energy expenditure, and on the other it leads to muscle 
atrophy. Another contributing factor is the use of medications 
such as glucocorticoids that cause increased appetite and fat 
accumulation.14
Regardless of etiology, increased body weight has im-
portant implications for these patients. The first is the me-
chanical burden imposed on the joints, especially those of 
the lower limbs, which are already weakened by chronic in-
flammation.15   They will suffer structural damage more easily 
leading to secondary osteoarthritis. The second is the already 
mentioned association between RA and accelerated athero-
genesis. Although in RA atherosclerotic disease is mainly sec-
ondary to inflammation, it also suffers influence of traditional 
risk factors including obesity.16 The sum of traditional risk 
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Fig. 1 – Prevalence (in %) of body mass indexes (BMI) in 102 
patients with rheumatoid arthritis.
Fig. 2 – Distribution of findings of triceps skinfold adequacy 
(in %).  Analyis of 102 rheumatoid arthritis patients. 
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factors and inflammation will increase the chance of stroke 
and myocardial infarction. According to Kremers et al.17, obe-
sity increases 10-fold the risk of a cardiovascular event in pa-
tients with RA.
Yet a third implication is the role of adipose tissue on the 
inflammatory process itself. Adipose tissue is not merely a 
deposit of energy elements but an organ that secretes biologi-
cally active molecules, the adipokines, many of which play 
a role in regulating inflammation.16 As a general rule, high 
levels of adipokines cause an increase in the inflammatory 
process in such a way that obesity is currently recognized as a 
pro inflammatory state.16 There are more than 50 adipokines, 
the most important of which are leptin, adiponectin, resistin 
and visfatin.16 Altered serum adipokine levels is associated 
with rheumatoid arthritis.18 Not only do they worsen an al-
ready settled RA but, according to some authors, obesity per se 
is associated with increased risk of developing RA.18 However 
data in this last issue are contradictory.17,19
We could not find correlation of use of glucocorticoid 
with nutritional status. It is well known from literature 
that this medication is associated with weight gain and in-
creased abdominal fat deposition.20 One explanation for this 
finding is that most of our patients were using low doses of 
this medication as is usually done in rheumatoid arthritis. 
Correlation with cumulative glucocorticoid exposure could 
offer further information, but unfortunately we did not have 
this information.
It must be remarked that, since we used only skinfolds 
as a measurement of nutritional status, this can be seen as 
a limitation; studies with DEXA could offer additional infor-
mation.
In conclusion, it can be said that there is a weight gain in 
subjects with RA despite of loss of muscle mass, mainly at 
the expense of adipose tissue. Obesity mass must be properly 
cared for in order to best treat patients with this disease.
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